These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32627007)

  • 1. Upregulated expression of MMP family genes is associated with poor survival in patients with esophageal squamous cell carcinoma via regulation of proliferation and epithelial‑mesenchymal transition.
    Xu G; Ou L; Liu Y; Wang X; Liu K; Li J; Li J; Wang S; Huang D; Zheng K; Wang S
    Oncol Rep; 2020 Jul; 44(1):29-42. PubMed ID: 32627007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TWIST1 upregulates matrix metalloproteinase (MMP) genes family in esophageal squamous carcinoma cells.
    Ardalan Khales S; Abbaszadegan MR; Majd A; Forghanifard MM
    Gene Expr Patterns; 2020 Sep; 37():119127. PubMed ID: 32711119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPI1-Mediated Upregulation of the
    Luo FF; Wang J; Zhang ZF; Lin ST; Huang TJ; Liu BQ; Fan ML; Peng LX; Zheng ST; Yang CF; Huang BJ
    Front Biosci (Landmark Ed); 2023 Sep; 28(9):212. PubMed ID: 37796690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of association of OCT4 with LEF1 expression in esophageal squamous cell carcinoma and their impact on epithelial-mesenchymal transition, invasion, and migration.
    Zhao Y; Li C; Huang L; Niu S; Lu Q; Gong D; Huang S; Yuan Y; Chen H
    Cancer Med; 2018 Aug; 7(8):3977-3987. PubMed ID: 29974668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between MMP-13, CD44, and TWIST1 and its role in regulation of EMT in patients with esophageal squamous cell carcinoma.
    Mahmoudian RA; Gharaie ML; Abbaszadegan MR; Alasti A; Forghanifard MM; Mansouri A; Gholamin M
    Mol Cell Biochem; 2021 Jun; 476(6):2465-2478. PubMed ID: 33604811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
    Li W; Liu J; Zhao H
    Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway.
    Mei LL; Qiu YT; Huang MB; Wang WJ; Bai J; Shi ZZ
    Cancer Biomark; 2017 Dec; 20(4):527-537. PubMed ID: 28800315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MT3-MMP down-regulation promotes tumorigenesis and correlates to poor prognosis in esophageal squamous cell carcinoma.
    Xue Z; Wu X; Chen X; Luo Q
    Cancer Med; 2016 Sep; 5(9):2459-68. PubMed ID: 27292876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Epithelial-Mesenchymal Transition- (EMT-) Related LncRNA for Prognostic Prediction and Risk Stratification in Esophageal Squamous Cell Carcinoma.
    Wang P; Chen Y; Zheng Y; Fu Y; Ding Z
    Dis Markers; 2021; 2021():5340240. PubMed ID: 34712369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics Analysis Reveals a Novel Prognostic Model for Esophageal Squamous Cell Carcinoma.
    Yang H; Chen Y; Huang X; Gu Y; Chen Z; Mao W
    Int J Med Sci; 2024; 21(7):1213-1226. PubMed ID: 38818465
    [No Abstract]   [Full Text] [Related]  

  • 12. Long non‑coding RNA MEG3 suppresses epithelial‑to‑mesenchymal transition by inhibiting the PSAT1‑dependent GSK‑3β/Snail signaling pathway in esophageal squamous cell carcinoma.
    Li MK; Liu LX; Zhang WY; Zhan HL; Chen RP; Feng JL; Wu LF
    Oncol Rep; 2020 Nov; 44(5):2130-2142. PubMed ID: 32901893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis.
    Zhao Y; Gao J; Xie X; Nan P; Liu F; Sun Y; Zhao X
    Cancer Med; 2021 May; 10(10):3413-3426. PubMed ID: 33932125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel fatty acid metabolism-related signature identifies MUC4 as a novel therapy target for esophageal squamous cell carcinoma.
    Li S; Liu Z; Chen Q; Chen Y; Ji S
    Sci Rep; 2024 May; 14(1):12476. PubMed ID: 38816411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of PDGFA predicts poor prognosis of esophageal squamous cell carcinoma.
    Han N; Zhang YY; Zhang ZM; Zhang F; Zeng TY; Zhang YB; Zhao WC
    Medicine (Baltimore); 2021 May; 100(20):e25932. PubMed ID: 34011067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway.
    Shan B; Man H; Liu J; Wang L; Zhu T; Ma M; Xv Z; Chen X; Yang X; Li P
    Oncol Rep; 2016 Sep; 36(3):1551-61. PubMed ID: 27430162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAGE-C3 promotes cancer metastasis by inducing epithelial-mesenchymal transition and immunosuppression in esophageal squamous cell carcinoma.
    Wu Q; Zhang W; Wang Y; Min Q; Zhang H; Dong D; Zhan Q
    Cancer Commun (Lond); 2021 Dec; 41(12):1354-1372. PubMed ID: 34347390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RASSF10 exhibits tumor‑suppressing potential involving tumor proliferation, metastasis and epithelial‑mesenchymal transition in esophageal squamous cell carcinoma.
    Liu Y; Zhu X; Zhang W; Bian T; Wu Z; Zhang J; Qiu H; Hu Y; Feng J; Shi J
    Oncol Rep; 2022 Apr; 47(4):. PubMed ID: 35211758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated analysis highlights multiple long non‑coding RNAs and their potential roles in the progression of human esophageal squamous cell carcinoma.
    Li CY; Zhang WW; Xiang JL; Wang XH; Wang JL; Li J
    Oncol Rep; 2019 Dec; 42(6):2583-2599. PubMed ID: 31638253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA‑181a promotes epithelial‑mesenchymal transition in esophageal squamous cell carcinoma via the TGF‑β/Smad pathway.
    Xu R; Zhou XM; Li YS; Ren L; He XR
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.